115 related articles for article (PubMed ID: 11843819)
1. Analysis of clonal B-cell CD38 and immunoglobulin variable region sequence status in relation to clinical outcome for B-chronic lymphocytic leukaemia.
Jelinek DF; Tschumper RC; Geyer SM; Bone ND; Dewald GW; Hanson CA; Stenson MJ; Witzig TE; Tefferi A; Kay NE
Br J Haematol; 2001 Dec; 115(4):854-61. PubMed ID: 11843819
[TBL] [Abstract][Full Text] [Related]
2. TLR-9 and IL-15 Synergy Promotes the In Vitro Clonal Expansion of Chronic Lymphocytic Leukemia B Cells.
Mongini PK; Gupta R; Boyle E; Nieto J; Lee H; Stein J; Bandovic J; Stankovic T; Barrientos J; Kolitz JE; Allen SL; Rai K; Chu CC; Chiorazzi N
J Immunol; 2015 Aug; 195(3):901-23. PubMed ID: 26136429
[TBL] [Abstract][Full Text] [Related]
3. Immunological aspects in chronic lymphocytic leukemia (CLL) development.
García-Muñoz R; Roldan Galiacho V; Llorente L
Ann Hematol; 2012 Jul; 91(7):981-96. PubMed ID: 22526361
[TBL] [Abstract][Full Text] [Related]
4. Calcium-RasGRP2-Rap1 signaling mediates CD38-induced migration of chronic lymphocytic leukemia cells.
Mele S; Devereux S; Pepper AG; Infante E; Ridley AJ
Blood Adv; 2018 Jul; 2(13):1551-1561. PubMed ID: 29970392
[TBL] [Abstract][Full Text] [Related]
5. Relation of gene expression phenotype to immunoglobulin mutation genotype in B cell chronic lymphocytic leukemia.
Rosenwald A; Alizadeh AA; Widhopf G; Simon R; Davis RE; Yu X; Yang L; Pickeral OK; Rassenti LZ; Powell J; Botstein D; Byrd JC; Grever MR; Cheson BD; Chiorazzi N; Wilson WH; Kipps TJ; Brown PO; Staudt LM
J Exp Med; 2001 Dec; 194(11):1639-47. PubMed ID: 11733578
[TBL] [Abstract][Full Text] [Related]
6. The pathogenic relevance of the prognostic markers CD38 and CD49d in chronic lymphocytic leukemia.
Brachtl G; Piñón Hofbauer J; Greil R; Hartmann TN
Ann Hematol; 2014 Mar; 93(3):361-74. PubMed ID: 24288111
[TBL] [Abstract][Full Text] [Related]
7. ZAP70 in B-CLL cells related to the expression in NK cells is a surrogate marker for mutational status.
Wiggers TG; Westra G; Westers TM; Abbes AP; Strunk A; Kuiper-Kramer E; Poddighe P; van de Loosdrecht AA; Chamuleau ME
Cytometry B Clin Cytom; 2013 Oct; ():. PubMed ID: 24124110
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of Somatic Hypermutation Status in Chronic Lymphocytic Leukemia (CLL) in the Era of Next Generation Sequencing.
Gupta SK; Viswanatha DS; Patel KP
Front Cell Dev Biol; 2020; 8():357. PubMed ID: 32509784
[TBL] [Abstract][Full Text] [Related]
9. Chronic lymphocytic leukaemia.
Kipps TJ; Stevenson FK; Wu CJ; Croce CM; Packham G; Wierda WG; O'Brien S; Gribben J; Rai K
Nat Rev Dis Primers; 2017 Jan; 3():16096. PubMed ID: 28102226
[TBL] [Abstract][Full Text] [Related]
10. The Value of Neutrophil Gelatinase-Associated Lipocalin Receptor as a Novel Partner of CD38 in Chronic Lymphocytic Leukemia: From an Adverse Prognostic Factor to a Potential Pharmacological Target?
Bauvois B; Chapiro E; Quiney C; Maloum K; Susin SA; Nguyen-Khac F
Biomedicines; 2023 Aug; 11(9):. PubMed ID: 37760777
[TBL] [Abstract][Full Text] [Related]
11. B cell receptor signaling proteins as biomarkers for progression of CLL requiring first-line therapy.
Vervoordeldonk MYL; Hengeveld PJ; Levin MD; Langerak AW
Leuk Lymphoma; 2024 Apr; ():1-13. PubMed ID: 38619476
[TBL] [Abstract][Full Text] [Related]
12. Untargeted metabolomics identifies metabolic dysregulation of sphingolipids associated with aggressive chronic lymphocytic leukaemia and poor survival.
Nguyen Van Long F; Valcourt-Gendron D; Caron P; Rouleau M; Villeneuve L; Simonyan D; Le T; Sergerie R; Laverdière I; Vanura K; Guillemette C
Clin Transl Med; 2023 Dec; 13(12):e1442. PubMed ID: 38037464
[TBL] [Abstract][Full Text] [Related]
13. Unveiling the dynamics and molecular landscape of a rare chronic lymphocytic leukemia subpopulation driving refractoriness: insights from single-cell RNA sequencing.
Kurucova T; Reblova K; Janovska P; Porc JP; Navrkalova V; Pavlova S; Malcikova J; Plevova K; Tichy B; Doubek M; Bryja V; Kotaskova J; Pospisilova S
Mol Oncol; 2024 May; ():. PubMed ID: 38770541
[TBL] [Abstract][Full Text] [Related]
14. Defining treatment success in chronic lymphocytic leukemia: exploring surrogate markers, comorbidities, and patient-centered endpoints.
Molica S
Expert Rev Hematol; 2024 Jun; ():1-7. PubMed ID: 38856076
[TBL] [Abstract][Full Text] [Related]
15. A Ferroptosis Molecular Subtype-Related Signature for Predicting Prognosis and Response to Chemotherapy in Patients with Chronic Lymphocytic Leukemia.
Gong H; Li H; Yang Q; Zhang G; Liu H; Ma Z; Peng H; Nie L; Xiao X; Liu J
Biomed Res Int; 2022; 2022():5646275. PubMed ID: 35845961
[TBL] [Abstract][Full Text] [Related]
16. Ectonucleotidases in Blood Malignancies: A Tale of Surface Markers and Therapeutic Targets.
Vaisitti T; Arruga F; Guerra G; Deaglio S
Front Immunol; 2019; 10():2301. PubMed ID: 31636635
[TBL] [Abstract][Full Text] [Related]
17. First Case of Transformation of Immunoglobulin Heavy Chain Variable-Mutated Chronic Lymphocytic Leukemia Into Chronic Myeloid Leukemia.
Zhang X; Guo X
Ann Lab Med; 2019 Nov; 39(6):577-579. PubMed ID: 31240887
[No Abstract] [Full Text] [Related]
18. Targeting CD38 Enhances the Antileukemic Activity of Ibrutinib in Chronic Lymphocytic Leukemia.
Manna A; Aulakh S; Jani P; Ahmed S; Akhtar S; Coignet M; Heckman M; Meghji Z; Bhatia K; Sharma A; Sher T; Alegria V; Malavasi F; Chini EN; Chanan-Khan A; Ailawadhi S; Paulus A
Clin Cancer Res; 2019 Jul; 25(13):3974-3985. PubMed ID: 30940652
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of CD38 expression in Sudanese patients with chronic lymphocytic leukemia.
Abdelgader EA; Eltayeb NH; Eltahir TA; Altayeb OA; Fadul EA; Abdel Rahman EM; Merghani TH
BMC Res Notes; 2018 Nov; 11(1):815. PubMed ID: 30442182
[TBL] [Abstract][Full Text] [Related]
20. Morphological, immunophenotypic, and genetic features of chronic lymphocytic leukemia with trisomy 12: a comprehensive review.
Autore F; Strati P; Laurenti L; Ferrajoli A
Haematologica; 2018 Jun; 103(6):931-938. PubMed ID: 29748447
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
